title: [Anti-tNFalpha therapy in chronic severe asthma].
authors.affiliation: Klinika Alergologii i Chorób Wewnetrznych Akademii Medycznej w Białymstoku
authors.forename: Maria Magdalena
authors.initials: MM
authors.lastname: Tomasiak
authors.forename: Ziemowit
authors.initials: Z
authors.lastname: Zietkowski
authors.forename: Marian
authors.initials: M
authors.lastname: Tomasiak
authors.forename: Roman
authors.initials: R
authors.lastname: Skiepko
authors.forename: Anna
authors.initials: A
authors.lastname: Bodzenta-Lukaszyk
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018927:Anti-Asthmatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept